228 related articles for article (PubMed ID: 11233905)
21. Impact of pronase on flow cytometric crossmatch outcome.
Hetrick SJ; Schillinger KP; Zachary AA; Jackson AM
Hum Immunol; 2011 Apr; 72(4):330-6. PubMed ID: 21262310
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of a positive flow crossmatch on the outcomes of cadaveric renal transplants.
Ilham MA; Winkler S; Coates E; Rizzello A; Rees TJ; Asderakis A
Transplant Proc; 2008; 40(6):1839-43. PubMed ID: 18675065
[TBL] [Abstract][Full Text] [Related]
23. Identification of patients at risk for inferior renal allograft outcome by a strongly positive B cell flow cytometry crossmatch.
Lazda VA
Transplantation; 1994 Mar; 57(6):964-9. PubMed ID: 8154047
[TBL] [Abstract][Full Text] [Related]
24. Crossmatching technique facilitating kidney transplantation.
Buabut B; Chiewsilp P; Patanapanyasat K; Jirasiritham S; Mavichak V; Sujirachato K; Mongkolsuk T
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S55-61. PubMed ID: 9347647
[TBL] [Abstract][Full Text] [Related]
25. The acceptable reactive crossmatch (ARC), post-transplant monitoring, and their impact on kidney transplantation: a single center experience.
Leone JP; Bowers V; Baliga R; Sanders C; LeFor W; Becker D; Thompson D; Resto-Ruiz S; Lopez-Cepero M
Clin Transpl; 2011; ():373-9. PubMed ID: 22755434
[TBL] [Abstract][Full Text] [Related]
26. The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients.
Lobashevsky AL; Senkbeil RW; Shoaf JL; Stephenson AK; Skelton SB; Burke RM; Deierhoi MH; Thomas JM
Hum Immunol; 2002 May; 63(5):364-74. PubMed ID: 11975980
[TBL] [Abstract][Full Text] [Related]
27. Modified flow cytometry crossmatch detecting alloantibody-related cytotoxicity as a way to distinguish lytic antibodies from harmless in allosensitised kidney recipients.
Zieliński M; Zielińska H; Moszkowska G; Dȩbska-Ślizień A; Rutkowski B; Trzonkowski P
Transplant Proc; 2013; 45(1):88-94. PubMed ID: 23375279
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric evaluation of pregnancy-induced anti-donor immunization.
Ayna TK; Ciftci HS; Tozkir H; Sagiroglu T; Isitmangil G; Gurtekin B; Gurtekin M
Transplant Proc; 2012; 44(6):1656-9. PubMed ID: 22841238
[TBL] [Abstract][Full Text] [Related]
29. Accuracy of the median channel shift in the flow cytometry for predicting complement dependent cytotoxicity crossmatching in kidney transplant candidates.
de Moraes P; Fagundes I; Cardone JM; Gil BC; Kulzer ASS; Hadi RA; Manfro RC; Jobim LF
Transpl Immunol; 2019 Feb; 52():27-31. PubMed ID: 30367965
[TBL] [Abstract][Full Text] [Related]
30. Weak humoral posttransplant alloresponse after a well-HLA-matched cadaveric kidney transplantation.
Matinlauri IH; Kyllönen LE; Eklund BH; Koskimies SA; Salmela KT
Transplantation; 2004 Jul; 78(2):198-204. PubMed ID: 15280678
[TBL] [Abstract][Full Text] [Related]
31. Rapid optimized flow cytometric crossmatch (FCXM) assays: The Halifax and Halifaster protocols.
Liwski RS; Greenshields AL; Conrad DM; Murphey C; Bray RA; Neumann J; Gebel HM
Hum Immunol; 2018 Jan; 79(1):28-38. PubMed ID: 29109009
[TBL] [Abstract][Full Text] [Related]
32. Flow cross-matching identifies patients at risk for postoperative elaboration of cytotoxic antibodies.
Kimball P; Rhodes C; King A; Fisher R; Ham J; Posner M
Transplantation; 1998 Feb; 65(3):444-6. PubMed ID: 9484770
[TBL] [Abstract][Full Text] [Related]
33. Clinical implications of flow cytometry crossmatch with T or B cells in living donor liver transplantation.
Takakura K; Kiuchi T; Kasahara M; Uryuhara K; Uemoto S; Inomata Y; Tanaka K
Clin Transplant; 2001 Oct; 15(5):309-16. PubMed ID: 11678956
[TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation.
Baranwal AK; Bhat DK; Goswami S; Agarwal SK; Kaur G; Kaur J; Mehra N
Indian J Med Res; 2017 Feb; 145(2):222-228. PubMed ID: 28639599
[TBL] [Abstract][Full Text] [Related]
35. The association between a positive T and B cell flow cytometry crossmatch and renal transplant failure.
Martin S; Liggett H; Robson A; Connolly J; Johnson RW
Transpl Immunol; 1993; 1(4):270-6. PubMed ID: 8081783
[TBL] [Abstract][Full Text] [Related]
36. Comparative study between cytotoxicity and flowcytometry crossmatches before and after renal transplantation.
Abdel Rahman AS; Fahim NM; El Sayed AA; El Hady SA; Ahmad YS
Egypt J Immunol; 2005; 12(2):77-89. PubMed ID: 17977213
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of flow cytometric panel reactive antibody in renal transplant recipients - examination of 238 cases of renal transplantation.
Ishida H; Tanabe K; Furusawa M; Ishizuka T; Hayashi T; Tokumoto T; Miyamoto N; Shirakawa H; Shimmura H; Shimizu T; Toma H
Transpl Int; 2005 Feb; 18(2):163-8. PubMed ID: 15691268
[TBL] [Abstract][Full Text] [Related]
38. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
[TBL] [Abstract][Full Text] [Related]
39. The complement interference phenomenon as a cause for sharp fluctuations of serum anti-HLA antibody strength in kidney transplant patients.
Guidicelli G; Anies G; Bachelet T; Dubois V; Moreau JF; Merville P; Couzi L; Taupin JL
Transpl Immunol; 2013 Dec; 29(1-4):17-21. PubMed ID: 24056164
[TBL] [Abstract][Full Text] [Related]
40. Image cytometry as an alternative to flow cytometry for the transplant histocompatibility crossmatch assay.
Ramon DS; Franks T; Jaramillo A; Paradis BD; Chan LL
HLA; 2019 Jun; 93(6):436-444. PubMed ID: 30838802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
